ZA200610190B - Heparin binding peptide - Google Patents

Heparin binding peptide

Info

Publication number
ZA200610190B
ZA200610190B ZA200610190A ZA200610190A ZA200610190B ZA 200610190 B ZA200610190 B ZA 200610190B ZA 200610190 A ZA200610190 A ZA 200610190A ZA 200610190 A ZA200610190 A ZA 200610190A ZA 200610190 B ZA200610190 B ZA 200610190B
Authority
ZA
South Africa
Prior art keywords
binding peptide
heparin binding
heparin
peptide
binding
Prior art date
Application number
ZA200610190A
Other languages
English (en)
Inventor
Bock Elisabeth
Berezin Vladimir
Original Assignee
Enkam Pharmaceuticals As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enkam Pharmaceuticals As filed Critical Enkam Pharmaceuticals As
Publication of ZA200610190B publication Critical patent/ZA200610190B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
ZA200610190A 2004-06-10 2006-12-06 Heparin binding peptide ZA200610190B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200400909 2004-06-10

Publications (1)

Publication Number Publication Date
ZA200610190B true ZA200610190B (en) 2008-08-27

Family

ID=35503712

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610190A ZA200610190B (en) 2004-06-10 2006-12-06 Heparin binding peptide

Country Status (10)

Country Link
US (1) US20080226639A1 (xx)
EP (1) EP1765862A2 (xx)
JP (1) JP2008503596A (xx)
CN (1) CN101027319A (xx)
AU (1) AU2005252297A1 (xx)
BR (1) BRPI0511914A (xx)
CA (1) CA2569662A1 (xx)
MX (1) MXPA06014402A (xx)
WO (1) WO2005121168A2 (xx)
ZA (1) ZA200610190B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009529490A (ja) * 2006-01-23 2009-08-20 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ ニューロンの可塑性および再生を増強するための組成物および方法
KR101171958B1 (ko) * 2009-09-17 2012-08-08 한국과학기술연구원 헤파린 결합 도메인을 이용한 지방줄기세포의 지방세포로의 분화방법
JP7413286B2 (ja) * 2018-06-18 2024-01-15 サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィック Ｇａｇとそれらのエフェクター分子との相互作用を制御するリガンドおよびその使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036945A (en) * 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4599311A (en) * 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
AU3418389A (en) * 1988-03-28 1989-10-16 Regents Of The University Of California, The Nerve growth factor peptides
US6333307B1 (en) * 1996-07-12 2001-12-25 Mcgill University Compounds and method for modulating neurite outgrowth
US7241730B2 (en) * 1998-08-27 2007-07-10 Universitat Zurich Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides
US6649756B2 (en) * 2000-07-13 2003-11-18 Wyeth, Five Giralda Farms Process improvement in the preparation of (4r, 5s, 6s)-3-[[(2r,3r)-2-[[[(s)-2-amino-3-methyl-1-oxobutyl]amino]methyl]tetrahydro-3-furanyl]thio]-6-[(r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
GB0018140D0 (en) * 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities

Also Published As

Publication number Publication date
CN101027319A (zh) 2007-08-29
CA2569662A1 (en) 2005-12-22
WO2005121168A2 (en) 2005-12-22
MXPA06014402A (es) 2007-03-08
AU2005252297A1 (en) 2005-12-22
EP1765862A2 (en) 2007-03-28
WO2005121168A3 (en) 2006-03-16
US20080226639A1 (en) 2008-09-18
BRPI0511914A (pt) 2008-01-15
JP2008503596A (ja) 2008-02-07

Similar Documents

Publication Publication Date Title
EP1827245A4 (en) BINDING COMPONENT
ZA200700895B (en) Polypeptide
GB0423974D0 (en) Proteins
ZA200610190B (en) Heparin binding peptide
GB0417887D0 (en) Protein
GB0415196D0 (en) Polypeptide
GB0402904D0 (en) Polypeptide
GB0416035D0 (en) Protein
GB0401882D0 (en) Protein
GB0423128D0 (en) Peptides
GB0425033D0 (en) Peptides
GB0418414D0 (en) Peptide
GB0415161D0 (en) Proteins
GB0405885D0 (en) Proteins
GB0412570D0 (en) Proteins
GB0418248D0 (en) Proteins
GB0418666D0 (en) Proteins
GB0423002D0 (en) Proteins
GB0405643D0 (en) Proteins
GB0411678D0 (en) Proteins
GB0400605D0 (en) Polypeptide
GB0400606D0 (en) Polypeptide
GB0401311D0 (en) Protein
GB0414086D0 (en) Protein
GB0405057D0 (en) Protein